Today, Cronos Group Inc. (NASDAQ: CRON) and Ginkgo Bioworks Inc.announced a landmark partnership to produce cultured cannabinoids. Using its platform ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE